Older generation non-LVC formulas show marked improvement upon using TK values vs K, while multivariable non-LVC formulas did not consistently improve.
The unique MOA may deliver a synergistic effect when prescribed post-surgically.
FDA approval of teprotumumab as therapeutic offers hope for patients.
Maximizing refractive surgery is key to ensuring prosperous future
John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.
The augmented reality headset compensates for central vision loss to enhance the visual clarity of patients with age-related macular degeneration and other conditions such as Stargardt disease.
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
Minimizing clinic visits, maximizing use of imaging modalities are key.
Ophthalmologists end their discussion on the management of dry eye disease with other ocular comorbidities highlighting key takeaways and prospective advances in care and outcomes.
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
Systemic immunosuppression may prevent devastating complication in patients.
Ophthalmologists can reduce IOP and medications with endocyclophotocoagulation while in the eye.
Procedure can improve best-corrected visual acuity, enhancing quality of life for patients.
Carl D. Regillo, MD, and Jennifer I. Lim, MD, emphasize the high regulatory standards of equivalence and safety of biosimilars in considering the role they will play in the evolving treatment landscape for retinal disorders.
Prompt and adequate action is a key to facilitating the best recovery in patients.
Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.
Working as an investigator can prove to be a positive experience for physicians
A patient's vision loss leads to another diagnosis
Dilsher S. Dhoot, MD, and A. Paul Chous, MA, OD, FAAO, discuss future directions and unmet needs in the field of retinal eye disease.
Dilsher S. Dhoot, MD, and A. Paul Chous, MA, OD, FAAO, discuss future directions and unmet needs in the field of retinal eye disease.
One obvious trend has been that dry eye disease is a concurrent problem for virtually all my patients, and we need to address it for optimum comfort and surgical results.
Short-term steroid use can alleviate patient discomfort.
Treatment of patients with COVID-19 should include ophthalmic considerations.
Andrew Lee, MD, Andrew Carey, MD, and Elizabeth Fortin, MD, sit down on this episode of the NeuroOp Guru to discuss neuro-ophthalmology, interprofessional eConsults, and whether they provide timely and valuable guidance